ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 17.47.
Share Price | ₹1,836.2 | Sep 19,2025 |
Market Cap | ₹21,024.5 Cr | |
Sales-TTM | ₹1,203.2 Cr | TTM-Standalone Results |
Price/Sales | 17.47x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹21,024.5 Cr] as on Sep 19,2025
(/) Sales [ ₹1,203.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 17.47x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '17.47 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 5.13x.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 15.39x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ONESOURCE SPECIALTY PHARMA | 1,203.2 | 17.47 | 21,024.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.39 | 397,342.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 17.05 | 164,555.0 |
CIPLA LTD | 27,811.2 | 4.58 | 127,259.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.38 | 122,898.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.29 | 110,394.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.48 | 109,835.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.42 | 104,346.0 |
LUPIN LTD | 23,375.9 | 4.02 | 93,917.9 |
AUROBINDO PHARMA LTD | 32,024.8 | 2.03 | 64,953.9 |
ABBOTT INDIA LTD | 6,589.9 | 9.77 | 64,384.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.03x |
Max industry PS | 17.47x |
Median industry PS | 7.39x |
Average industry PS | 8.08x |
You may also like the below Video Courses